Table 6 Differences in breastfeeding and non-breastfeeding mothers with JIA 12 months postpartum
From: Breastfeeding in women with juvenile idiopathic arthritis: results from a Norwegian quality register
N | Breastfeeding N = 80 | N | Non-breastfeeding N = 125 | p-valuea | |
|---|---|---|---|---|---|
Patient background | |||||
Age (years), mean (SD) | 80 | 30.2 (4.2) | 125 | 29.5 (4.7) | 0.231 |
Age > 35 years, n (%) | 9 (11.3) | 13 (10.4) | 1.000 | ||
BMI (kg/m2), mean (SD) | 76 | 24.2 (4.5) | 110 | 25.2 (4.8) | 0.131 |
Overweight ≥ 25 kg/m2), n (%) | 29 (38.2) | 44 (40.0) | 0.460 | ||
Working full time or part time, n (%) | 79 | 50 (63.3) | 123 | 63 (51.2) | 0.123 |
Regular physical activity, n (%)b | 64 | 33 (51.6) | 84 | 50 (59.5) | 0.424 |
Cigarette/Snuff use, n (%) | 78 | 5 (6.4) | 120 | 18 (15.0) | 0.073 |
Education level, n (%)c | 78 | 122 | 0.056 | ||
Low | 2 (2.6) | 5 (4.1) | |||
Intermediate | 11 (14.1) | 34 (27.9) | |||
High | 65 (83.3) | 83 (68.0) | |||
Disease related characteristics | |||||
CRP (mg/L), mean (SD) | 67 | 4.2 (5.5) | 110 | 4.9 (6.4) | 0.226 |
CRP value > 5 mg/L, n (%) | 17 (25.4) | 32 (29.1) | 0.717 | ||
DAS-28-CRP-3, mean (SD) | 60 | 2.4 (0.8) | 101 | 2.5 (0.8) | 0.224 |
Remission (DAS-28-CRP-3 < 2.6), n (%) | 40 (66.7) | 58 (57.4) | 0.32 | ||
Active disease (DAS-28-CRP-3 ≥ 2.6), n (%) | 20 (33.3) | 43 (42.6) | 0.32 | ||
VAS-score (mm), mean (SD) | |||||
Pain | 71 | 26.7 (24.0) | 98 | 33.8 (33.4) | 0.281 |
Fatigue | 33.5 (27.4) | 93 | 38.6 (29.0) | 0.324 | |
Total | 70 67 | 31.4 (26.8) | 98 | 34.7 (29.1) | 0.689 |
Medications | |||||
csDMARDs, n (%) | 80 | 24 (30.0) | 123 | 47 (38.2)d | < 0.001 |
Hydroxychloroquine, n (%) | 2 (2.5) | 10 (8.1) | |||
Methotrexate, n (%) | 1 (1.3) | 23 (18.7) | |||
Sulfasalazine, n (%) | 21 (26.3) | 15 (12.2) | |||
bDMARDs, n (%) | 80 | 125 | 0.396 | ||
TNF inhibitor, n (%) | 35 (43.8) | 63 (50.4) | |||
IL-6 inhibitor, n (%) | 1 (1.25) | 4 (3.2) | |||
Corticosteroids, n (%) | 80 | 16 (20.0) | 125 | 17 (13.6) | 0.322 |